Most long-term data is pending
2031/2012 of 9 March, 2012
Serious side effects are rare but may require immediate medical attention
Preclinical and Mechanistic Work Animal research suggests cannabinoids can influence the same metabolic pathways that GLP-1 drugs target
Superoxide measurements in liver and kidney by electron paramagnetic resonance (EPR) spectroscopy Mitochondrial superoxide in liver and kidney tissue was measured by EPR spectroscopy using a mitochondrial targeted probe, 1-hydroxy-4-[2-triphenylphosphonio)-acetamido]-2,2,6,6-tetramethylpiperidine,1-Hydroxy-2,2,6,6-tetramethyl-4-[2-(triphenylphosphonio)acetamido] piperidinium dichloride (mito-TEMPO-H) (Enzo Life Sciences, Farmingdale, NY) 24,25
Results showed a significant reduction in risk for RA in patients treated with GLP-1 receptor agonists (HR = 0.87